Kinetics of High-Mobility Group Box 1 after Living Donor Liver Transplantation
Hiroshi Sadamori(Okayama University), Toshiyoshi Fujiwara(Okayama University), Yasuharu Sato(Okayama University), Daisuke Sato(Okayama University), Takahito Yagi(Okayama University), Daisuke Nobuoka(Fukuyama City Hospital), Masahiro Sugihara(Okayama University), Masahiro Nishibori(Okayama University)
Cited by 0
Related Papers
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258